CSPC Pharmaceutical Reports 9M Net Profit Attributable of RMB 1.21 Billion
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
COSCO Shipping Holdings H Shares Jump 7.3%
The company's H shares rose as much as 7.3%; its A shares gained as much as 5.9% in early Friday trading. Third-quarter net profit increased by more than eight-tenths year over yea
M impact | EARNINGS | Oct 30, 2026, 01:50 AM UTC
Polydamic Group Swings to FY26 Profit of RM 1.28 Million
M impact | EARNINGS | Oct 30, 2026, 01:48 AM UTC
Bristol Myers beats quarterly estimates, raises full-year sales outlook
Bristol Myers reported quarterly results above expectations and raised its full-year sales forecast, citing strong performance from new drugs.
M impact | EARNINGS | Oct 30, 2026, 01:48 AM UTC
Kingsgate sets FY27 production guidance
Kingsgate Consolidated forecasts FY27 production of 75–85koz of gold, 650–750koz of silver and 82–93koz of AUEQ.
M impact | EARNINGS | Oct 30, 2026, 01:47 AM UTC
Metsä Board Sees Annual Investment Below the Reported Threshold in 2026–2030
Metsä Board expects annual investment to be well below the reported threshold from 2026 through 2030.
L impact | EARNINGS | Oct 30, 2026, 01:47 AM UTC
Vamos Reports Net Profit in 3Q26, Up 199% From 3Q25
Vamos reported net profit in 3Q26, up 199% from 3Q25.
M impact | EARNINGS | Oct 30, 2026, 01:42 AM UTC